Jefferies Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,800
Closed -$2.93M 1838
2024
Q4
$2.93M Buy
+3,800
New +$3.15M 0.02% 533
2024
Q1
Sell
-39,500
Closed -$23M 1844
2023
Q4
$23M Sell
39,500
-8,300
-17% -$4.84M 0.15% 97
2023
Q3
$25.7M Sell
47,800
-5,800
-11% -$2.99M 0.23% 63
2023
Q2
$25.1M Buy
53,600
+14,100
+36% +$5.91M 0.23% 80
2023
Q1
$13.6M Sell
39,500
-26,400
-40% -$8.9M 0.11% 159
2022
Q4
$24.1M Buy
+65,900
New +$23.4M 0.17% 95

Other funds holding LLY

Jefferies Financial Group's LLY Position: Q2 2026 in Review

Jefferies Financial Group reduced its Eli Lilly (LLY) stake by 64% in Q2 2026, selling an estimated $15.1M and leaving 8,250 shares worth $9.9M. The position accounts for 0.07% of the portfolio, ranked #250.

Jefferies Financial Group first reported a position in LLY in Q1 2016 and has held it in 16 quarters since. The position peaked at $229M in Q3 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Jefferies Financial Group held 8,250 shares of Eli Lilly worth $9.9M as of Q2 2026.
  • Jefferies Financial Group sold 14,780 Eli Lilly shares in Q2 2026, an estimated $15.1M.
  • Eli Lilly made up 0.07% of Jefferies Financial Group's portfolio in Q2 2026, its #250 holding.
  • Jefferies Financial Group first reported a position in Eli Lilly in Q1 2016 and has held it in 16 quarters since.
  • Jefferies Financial Group's Eli Lilly position peaked at $229M in Q3 2025.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.